Hoppa till innehållet

OMXSPI+0,81%

S&P 500+0,80%

FTSE 100+0,54%

DAX+0,01%

NIKKEI+1,13%
Redeye: Surgical Science Sweden Q4 2023 - Long-term high quality, short-term black box

Redeye updates its estimates following Surgical Science’s Q4 2023 report, which featured an unusually soft end to the year that we failed to anticipate. We believe the company’s long-term equity story remains unchanged, though 2023 showed how the market has difficulty pricing the considerable sequential volatility of the company’s sales.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Surgical Science Sweden Q4 2023 - Long-term high quality, short-term black box

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera